Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1841

Actual shortage: 45 (2%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1782 (97%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ ATORVASTATIN 80MG TABLET Resolved 2023-12-19 2024-01-24 213798
SANDOZ ATORVASTATIN 10MG TABLET Resolved 2024-01-03 2024-03-12 214771
SANDOZ ATORVASTATIN 10MG TABLET Resolved 2024-02-20 2024-02-27 219970
SANDOZ ATORVASTATIN 20MG TABLET Actual shortage 2024-04-30 2024-05-01 226664
SANDOZ ATORVASTATIN 40MG TABLET Actual shortage 2024-05-21 2024-05-22 228415
SANDOZ ATORVASTATIN 10MG TABLET Resolved 2023-11-22 2024-02-27 211127
SANDOZ ATORVASTATIN 40MG TABLET Resolved 2023-12-11 2024-01-03 213002
SANDOZ ATORVASTATIN 40MG TABLET Resolved 2023-12-11 2024-02-20 213005
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2020-04-21 2020-05-19 112668
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-05-10 2022-05-24 160309
SANDOZ AZITHROMYCIN 100MG POWDER FOR SUSPENSION Resolved 2022-06-09 2022-06-23 162354
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-06-09 2022-07-14 162357
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-06-17 2022-07-14 162962
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-06-22 2022-07-21 163234
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-07-29 2022-08-18 165773
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-07-29 2022-08-18 165776
SANDOZ AZITHROMYCIN 100MG POWDER FOR SUSPENSION Resolved 2022-10-12 2022-11-26 171547
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-11-02 2022-11-29 173364
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-11-16 2022-11-29 174963
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-11-28 2023-01-19 175980

Showing 901 to 920 of 1841

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82